We are live on ! Find out more
BA

Broadview Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 0.76%
This Fund
S&P 500
This Quarter Est. Return
+1.84%
1 Year Est. Return
-0.76%
3 Year Est. Return
+65.3%
5 Year Est. Return
+87.94%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$29.3M
Cap. Flow
+$17M
Cap. Flow %
1.65%
Top 10 Hldgs %
24.58%
Holding
106
New
6
Increased
26
Reduced
55
Closed
11

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$9.84M
2
GTLS
Chart Industries
GTLS
+$8.56M
3
ASTE icon
Astec Industries
ASTE
+$8.37M
4
FEIC
FEI COMPANY
FEIC
+$7.7M
5
PRXL
Parexel International Corp
PRXL
+$7.32M

Top Sells

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$12.4M
2
BEAV
B/E Aerospace Inc
BEAV
+$11M
3
RCL icon
Royal Caribbean
RCL
+$9.93M
4
ROC
ROCKWOOD HLDGS INC
ROC
+$8.2M
5
MDAS
MEDASSETS INC COM STK (DE)
MDAS
+$4.27M

Sector Composition

Rank Sector Weight
1 Industrials 22.81%
2 Consumer Discretionary 17.87%
3 Healthcare 15.78%
4 Technology 14.64%
5 Miscellaneous 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STGW icon
1
Stagwell
STGW
$2.14B
$33.7M 3.28%
1,569,520
+124,250
+9% +$2.79M
PTC icon
2
PTC
PTC
$17.1B
$31.1M 3.02%
800,844
+128,800
+19% +$4.64M
MINI
3
DELISTED
Mobile Mini Inc
MINI
$28.3M 2.76%
591,937
-42,150
-7% -$1.87M
HXL icon
4
Hexcel
HXL
$7.17B
$26M 2.53%
635,129
-10,150
-2% -$422K
INFA
5
DELISTED
INFORMATICA CORP
INFA
$24.3M 2.36%
681,800
+63,100
+10% +$2.32M
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
$23.7M 2.31%
1,652,425
-400
-0% -$5.22K
UHS icon
7
Universal Health Services
UHS
$10.1B
$23.2M 2.26%
242,575
-22,350
-8% -$1.93M
MAS icon
8
Masco
MAS
$14.4B
$21.5M 2.09%
1,100,787
-72,150
-6% -$1.36M
EHC icon
9
Encompass Health
EHC
$11.9B
$21M 2.04%
734,593
-189
-0% -$5.27K
IPG
10
DELISTED
Interpublic Group of Companies
IPG
$20M 1.94%
1,024,950
+206,200
+25% +$3.74M
GNTX icon
11
Gentex
GNTX
$4.78B
$19.5M 1.9%
1,340,450
+129,400
+11% +$1.89M
FFIV icon
12
F5
FFIV
$22.3B
$18.7M 1.82%
167,977
-3,750
-2% -$404K
CE icon
13
Celanese
CE
$4.94B
$17.6M 1.71%
273,100
-47,250
-15% -$2.87M
MTG icon
14
MGIC Investment
MTG
$6.36B
$17.5M 1.7%
1,892,450
-450
-0% -$3.91K
PRXL
15
DELISTED
Parexel International Corp
PRXL
$17.2M 1.68%
326,186
+145,950
+81% +$7.32M
VIVO
16
DELISTED
Meridian Bioscience Inc
VIVO
$17.2M 1.67%
834,185
+191,550
+30% +$3.94M
KMT icon
17
Kennametal
KMT
$2.25B
$17.2M 1.67%
371,650
-100
-0% -$4.63K
VMC icon
18
Vulcan Materials
VMC
$35.6B
$16.7M 1.63%
262,225
-50
-0% -$3.16K
FTNT icon
19
Fortinet
FTNT
$122B
$16.6M 1.61%
3,299,355
+1,471,855
+81% +$6.59M
NCMI icon
20
National CineMedia
NCMI
$245M
$16.6M 1.61%
94,657
+18,195
+24% +$2.89M
TEX icon
21
Terex
TEX
$7.28B
$16.5M 1.61%
402,575
+30,500
+8% +$1.24M
ZION icon
22
Zions Bancorporation
ZION
$9.89B
$16.3M 1.59%
553,675
-118,850
-18% -$3.49M
KATE
23
DELISTED
Kate Spade & Company
KATE
$16.3M 1.58%
427,278
– –
RRX icon
24
Regal Rexnord
RRX
$10.5B
$15.5M 1.5%
196,675
-50
-0% -$3.79K
VECO icon
25
Veeco
VECO
$2.71B
$15.4M 1.5%
413,025
+65,400
+19% +$2.34M
1
2 3 4 5

Similar funds

HJA
Hugh Johnson Advisors Albany, New York $320M AUM 9.58% 1-Year Est. Return
HCM
Harvest Capital Management Concord, New Hampshire $347M AUM 4.08% 1-Year Est. Return
MBT
Monroe Bank & Trust Monroe, Michigan $299M AUM 8.4% 1-Year Est. Return
HI
Honeywell International Charlotte, North Carolina $258M AUM 6.33% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
MM
Midas Management New York $231M AUM 7.96% 1-Year Est. Return
BLA
Balter Liquid Alternatives Boston, Massachusetts $205M AUM 2.95% 1-Year Est. Return

Broadview Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Broadview Advisors held 106 positions worth $1.03B, up 2.9% from $999M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Broadview Advisors's Q2 2014 filing shows 6 new, 26 increased, 55 reduced and 11 closed positions. Its largest new stake was Exact Sciences: 714,300 shares worth $12.2M. The largest sale was Myriad Genetics, an estimated $12.4M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Broadview Advisors's largest Q2 2014 buy was Exact Sciences: 714,300 shares worth $12.2M.
  • Broadview Advisors added most to Parexel International Corp in Q2 2014, an estimated $7.32M increase.
  • Broadview Advisors's biggest Q2 2014 reduction was ROCKWOOD HLDGS INC, cutting an estimated $8.2M.
  • Broadview Advisors fully exited Myriad Genetics in Q2 2014, selling an estimated $12.4M.
  • Broadview Advisors's ten largest holdings make up 25% of its $1.03B portfolio in Q2 2014.
  • Broadview Advisors opened 6 new positions and closed 11 in Q2 2014.
  • Broadview Advisors's portfolio value rose 2.9% quarter-over-quarter to $1.03B.

Based on Broadview Advisors's 13F filing for Q2 2014, filed 15 Aug 2014.